one8zero8 LLC Buys Shares of 10,900 Revvity Inc. $RVTY

one8zero8 LLC bought a new stake in shares of Revvity Inc. (NYSE:RVTY) in the second quarter, Holdings Channel reports. The fund bought 10,900 shares of the company’s stock, valued at approximately $1,213,000.

Several other large investors also recently modified their holdings of the stock. EdgePoint Investment Group Inc. raised its holdings in shares of Revvity by 3.1% in the 1st quarter. EdgePoint Investment Group Inc. now owns 8,800,863 shares of the company’s stock worth $771,044,000 after purchasing an additional 265,204 shares during the period. Price T Rowe Associates Inc. MD grew its holdings in Revvity by 5.3% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,606,637 shares of the company’s stock valued at $832,693,000 after purchasing an additional 434,570 shares during the period. Janus Henderson Group PLC increased its position in Revvity by 2.3% in the first quarter. Janus Henderson Group PLC now owns 8,348,127 shares of the company’s stock worth $731,386,000 after buying an additional 186,956 shares during the last quarter. BlackRock Inc. purchased a new stake in Revvity in the second quarter worth $852,070,000. Finally, Dimensional Fund Advisors LP raised its stake in shares of Revvity by 11.7% in the first quarter. Dimensional Fund Advisors LP now owns 2,917,953 shares of the company’s stock valued at $255,623,000 after buying an additional 305,837 shares during the period. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on RVTY. Sanford C. Bernstein started coverage on Revvity in a research report on Friday, June 26th. They set a “market perform” rating and a $115.00 price target on the stock. Wall Street Zen lowered Revvity from a “buy” rating to a “hold” rating in a report on Sunday. Weiss Ratings upgraded Revvity from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 30th. Wolfe Research assumed coverage on shares of Revvity in a report on Tuesday, June 2nd. They set a “peer perform” rating on the stock. Finally, Stifel Nicolaus reduced their target price on shares of Revvity from $110.00 to $100.00 and set a “hold” rating for the company in a research note on Wednesday, May 6th. Three analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $108.36.

Revvity Stock Up 4.9%

RVTY stock opened at $119.33 on Thursday. The stock has a 50-day simple moving average of $110.49 and a two-hundred day simple moving average of $100.09. Revvity Inc. has a twelve month low of $81.22 and a twelve month high of $122.11. The firm has a market capitalization of $13.32 billion, a PE ratio of 56.82, a PEG ratio of 2.07 and a beta of 1.07. The company has a quick ratio of 1.50, a current ratio of 1.80 and a debt-to-equity ratio of 0.36.

Revvity (NYSE:RVTY) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.21 by $0.20. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The firm had revenue of $729.69 million for the quarter, compared to the consensus estimate of $702.96 million. During the same period in the prior year, the firm posted $1.18 earnings per share. The company’s revenue for the quarter was down 1.3% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. On average, equities analysts predict that Revvity Inc. will post 5.36 EPS for the current fiscal year.

Revvity Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be paid a $0.07 dividend. The ex-dividend date is Friday, October 23rd. This represents a $0.28 annualized dividend and a yield of 0.2%. Revvity’s dividend payout ratio is currently 13.33%.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.